Schizophrenia
Cluster Number:
Wiki Number: PW195
Diagnosis: Schizophrenia
US Patients: 1.1% of the population;Life expectancy decreased by 20 years; sedentary life leads to heart attacks;
World Patients: 20 million total cases; 16.7 Million-disabled due to schizophrenia, 75% unemployed; Violence-6X population; with alcohol-24X.
Sex Ratio: M+;F
Age Onset: M-early 20’s; F-late 20’s and post-menopausal in women. Psychosis (reality-unreality) often preceeds schizophrenia.
Brain Area: dopamine controls positive motivations; genes CRHR1 and CRHBP relate to suicidal behavior, several brain areas involved
Symptoms: Hallucinations, delusions, disorganized thinking, withdrawal, apathy, weak emotions, word salad; cognitively poorer generally
Progression: Usually non-violent; more likely to be victims,unless using alcohol or drugs.
Causes: 70-80% heritable; raised in city, older parents, drugs or pot used as teenager, several factors during pregnancy; childhood traumas
Medications: antipsychotics, hospitalization to stop harm to self or others, many create restlessness, muscle-jerking, weight gain
Therapies: exercise, CBTs, other talking therapies, along with medications, ½improve, some get well; the other half, life-time involvement.
Youtube Video: How Paranoid Schizophrenia Impacts My Life
Youtube Video: What is Schizophrenia?
Amazon or Library Book: Surviving Schizophrenia
Click the book to link or order from Amazon.
Support Group: sczaction.org 1-800-493-2094
(Schizophrenia Action Alliance)
Contact your local Social Security office for possible Disability Benefits under their Disability Determination Services,
Section 12.03.
4 CURRENT ARTICLES
FROM PUBMED
The world-wide medical research
reports chosen for each diagnosis
Clicking each title opens the
PubMed article’s summary-abstract.
- Population Pharmacokinetic Modeling of TV-46000, a Risperidone Long-Acting Subcutaneous Antipsychotic for the Treatment of Patients with Schizophreniaby Itay Perlstein on March 24, 2025
CONCLUSIONS: The developed popPK model, together with corresponding simulations, supports TV-46000 as a LASCA that offers flexible dosing intervals (q1m or q2m) and administration sites (abdomen or upper arm) and does not require oral supplementation or loading dose(s).
- The Suppression of Depression as Multimediation: Psychiatric Diagnoses Under Myanmar's Military Dictatorshipby Stefan Ecks on March 24, 2025
Myanmar has experienced decades of military dictatorship, civil wars, religious violence, economic crises, and natural disasters. While these conditions would suggest very high rates of depression and anxiety, government statistics report an exceptionally low depression rate of 0.00006%, compared to the global rate of 3.4%. This study combines analysis of epidemiological data, ethnographic observation of clinics, and in-depth interviews. I argue that Myanmar's low depression rates cannot be...
- Both slow wave and rapid eye movement sleep contribute to emotional memory consolidationby Cagri Yuksel on March 24, 2025
Sleep supports memory consolidation, but the specific roles of different sleep stages in this process remain unclear. While rapid eye movement sleep (REM) has traditionally been linked to the processing of emotionally charged material, recent evidence suggests that slow wave sleep (SWS) also plays a role in strengthening emotional memories. Here, we use targeted memory reactivation (TMR) during REM and SWS in a daytime nap to directly examine which sleep stage is primarily involved in...
- The Use Of Antipsychotics In The Treatment Of Catatonia: A Systematic Reviewby M Redon on March 24, 2025
No abstract